Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin as Add-on to Methylprednisolone in Acute Optic Neuritis (VISION PROTECT)
NCT00355095Phase 2Completed
- Sponsor
- Institut für anwendungsorientierte Forschung und klinische Studien
- Start
- Aug 2006
- Primary completion
- Feb 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of erythropoietin in optic neuritis (ON), sponsored by Institut für anwendungsorientierte Forschung und klinische Studien. Started Aug 2006; status: completed.
02
Drugs
erythropoietin
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT00355095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00355095.